Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
Author(s): Rasha Al-Lamee , Michael Foley Added: 1 year ago
ACC.24 — Investigators, Dr Rasha K Al-Lamee and Dr Michael Foley (Imperial College London, UK) joined us to discuss the ORBITA COSMIC trial (NCT04892537).This randomized, double-blinded, placebo-controlled trial investigated the effects of coronary sinus reducer (CSR) as compared to placebo on myocardial perfusion via MRI, exercise duration, and symptoms in patients with refractory angina and… View more

Prevention & Chronic Conditions
CardioNerds @AHA23: ORBITA-2: PCI for Stable Angina
Author(s): Rasha Al-Lamee , Christopher Rajkumar , Nazli Okumus Added: 1 year ago
AHA 2023 — Investigators of ORBITA-2 trial, Dr Rasha Al-Lamee and Dr Christopher Rajkumar (Imperial College London, UK) talked with CardioNerds Ambassador, Dr Nazli Okumus about the randomised, placebo-controlled trial (NCT03742050) that compared the effects of coronary angioplasty versus placebo procedure on symptoms of stable angina without background anti-anginal therapy at 12 weeks.The ORBITA… View more

Intervention
Yield and Characterisation of CFT in ANOCA
Author(s): Johanna McChord , Astrid Hubert , Udo Sechtem , et al Added: 6 months ago

Prevention & Chronic Conditions
Research Area(s) / Expertise:
AHA 23: SUPER LIPID
Author(s): Alexander Fanaroff Added: 1 year ago
AHA 2023 — We are joined by Dr Alexander Fanaroff (Penn Medicine, US) to discuss the findings from a cluster randomised trial of automated referral to centralised pharmacy services for evidence-based statin initiation in high-risk patients.Gaps have been observed in evidence-based statin prescriptions, where more than 50% of US adults with an indication for atherosclerotic cardiovascular disease… View more

Prevention & Chronic Conditions
Bridging the Gap in HF Guideline Implementation
Author(s): Carys Barton Added: 8 months ago
ESC Congress — Ms Carys Barton (Imperial College Healthcare NHS Trust, London, UK) joins us on-site to talk about the implementation of heart failure guidelines.Interview Questions:1. What are the biggest challenges in implementing heart failure guidelines?2. How do nurses help implement guidelines, and what strategies do they use?3. What training can help with guideline implementation?4. How can… View more

Guidelines & Statements

Heart Failure
Ranil de Silva
Research Area(s) / Expertise:

Coronary Artery Disease

Coronary Interventions

 Job title: Senior Lecturer in Clinical Cardiology and Consultant Interventional Cardiologist
Dr Ranil de Silva is a Senior Lecturer in Clinical Cardiology and Consultant Interventional Cardiologist at the Royal Brompton Hospital, where he leads the Specialist Angina Service. Dr de Silva completed his training in general and interventional cardiology in London, including at the Royal Brompton, Hammersmith and St Mary’s Hospitals. He undertook post-doctoral research at the Division of… View more
REDUCE-IT: CV Outcomes With Icosapent Ethyl by Baseline LDL-C
Author(s): Deepak L Bhatt Added: 2 months ago
In this insightful interview, Dr Deepak Bhatt (Mount Sinai Hospital, US) joins us to discuss findings from a post-hoc analysis of the REDUCE-IT trial, examining how icosapent ethyl affects cardiovascular outcomes across different baseline LDL-C levels.The study included 8,175 statin-treated patients with elevated cardiovascular risk and triglyceride levels between 135-499mg/dL. All participants… View more

Prevention & Chronic Conditions
A Preferred Substrate-based Nomenclature in Myocardial Ischaemic Syndromes
Author(s): William E Boden , Juan Carlos Kaski , C Noel Bairey Merz , et al Added: 2 weeks ago

MI/ACS
Peter Ong
Research Area(s) / Expertise:
Dr Peter Ong is a Consultant Cardiologist in the Department of Cardiology and Angiology at theRobert-Bosch Hospital, Stuttgart, Germany. Dr Ong is a specialist in internal medicine and cardiology, and is qualified in intensive care medicine and interventional cardiology. Dr Ong's research interests include patients with angina and unobstructed coronary arteries. Dr Peter Ong is Section… View more